Kinesio Taping Along With Functional Activation Pattern in Stroke Patients (NCT05425212) | Clinical Trial Compass
CompletedNot Applicable
Kinesio Taping Along With Functional Activation Pattern in Stroke Patients
Pakistan16 participantsStarted 2022-04-04
Plain-language summary
In stroke; gait deviation occurs usually due to weakness in the tibialis anterior and over activation/spasticity of planter flexors. The lack of ability to dorsiflex properly contributes to foot drop that leads to the issue in proper foot clearance. This results in decreased walking speed, decreased stance and asymmetrical step length. If these issues will be addressed through application of kinesio tape and functional activation pattern throughout the gait cycle; this may improve lower limb kinematics in terms of gait parameters and dynamic balance. Therefore, current study gives us insight to gain the combined effects of KT and functional activation patterns in chronic stroke patients.
Who can participate
Age range
45 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* ● Both male and female, with age between 45-65 years
* Patients diagnosed with stroke for at least 6 months confirmed with MRI or CT.
* Patients depicting reduced range of motion at ankle joint after stroke causing gait disturbances.
* Ability to walk at least 3 meters by itself with or without assistive device.
* No surgical procedure performed on lower limbs.
* Normal vision with or without correction by spectacles or contact lenses
* Patients with spasticity \<2/5 on modified Ashworth scale
Exclusion Criteria:
* Patients with pre-existing neurological conditions who are Unable to understand and answer a simple verbal command.
* Patients with deep vein thrombosis (DVT). Using KT near the DVT can increase mobility and blood flow. This may cause the blood clot to dislodge and may put you at risk for pulmonary embolism.
* Cognitively impaired patients.
* Patients with open wounds in the lower extremity.
* Patients with ankle fracture or any skin allergy to adhesives.
* Patients with sensory loss due to any pathology, altered sensation such as in peripheral neuropathy.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.